Company / Depreciation & Amortization
ORTHOPEDIATRICS CORP Depreciation & Amortization History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$17.4M
FY2025
5-year range
$4.7M / $17.4M
FY2021-FY2025
Trend
+32.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 8 consecutive years, from $2M in FY2017 to $17M in FY2025.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of +43.2%.
Increased from $11M to $17M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +29.5%
- 5-Year CAGR
- +43.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- ORTHOPEDIATRICS CORP's depreciation & amortization has grown for 8 consecutive years.
- 5-year CAGR of +43.2%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 32.7% year-over-year.
- Lowest depreciation & amortization in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.4M | +32.7% |
| FY2024 | $13.1M | +22.6% |
| FY2023 | $10.7M | +33.3% |
| FY2022 | $8.0M | +71.5% |
| FY2021 | $4.7M | +61.5% |
| FY2020 | $2.9M | +20.2% |
| FY2019 | $2.4M | +26.4% |
| FY2018 | $1.9M | +2.6% |
| FY2017 | $1.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026